Access cutting-edge fuchs dystrophy treatment through this clinical trial at a research site in Lebanon. Study-provided care at no cost to qualified participants.
Access fuchs dystrophy specialists in Lebanon at no cost
This study follows strict safety protocols and ethical guidelines
All study-related fuchs dystrophy treatment provided free
Descemet Endothelial Thickness Comparison Trial (DETECT) II is a multi-center, outcome assessor-masked, placebo-controlled clinical trial randomizing 60 patients with Fuchs endothelial dystrophy to DMEK versus Descemet Stripping Only (DSO) with adjunctive Ripasudil.
Sponsor: Stanford University
Check if you qualify for this fuchs dystrophy clinical trial in Lebanon, NH
If you're searching for fuchs dystrophy treatment options in Lebanon, NH, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lebanon research site is actively enrolling participants for this clinical trial. You'll receive care from experienced fuchs dystrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.